Literature DB >> 24866144

L-Citrulline, but not L-arginine, prevents diabetes mellitus-induced glomerular hyperfiltration and proteinuria in rat.

Patrik Persson, Angelica Fasching, Tom Teerlink, Peter Hansell, Fredrik Palm.   

Abstract

Diabetes mellitus–induced oxidative stress causes increased renal oxygen consumption and intrarenal tissue hypoxia. Nitric oxide is an important determinant of renal oxygen consumption and electrolyte transport efficiency. The present study investigates whether l-arginine or l-citrulline to promote nitric oxide production prevents the diabetes mellitus–induced kidney dysfunction. Glomerular filtration rate, renal blood flow, in vivo oxygen consumption, tissue oxygen tension, and proteinuria were investigated in control and streptozotocin-diabetic rats with and without chronic l-arginine or l-citrulline treatment for 3 weeks. Untreated and l-arginine–treated diabetic rats displayed increased glomerular filtration rate (2600±162 versus 1599±127 and 2290±171 versus 1739±138 μL/min per kidney), whereas l-citrulline prevented the increase (1227±126 versus 1375±88 μL/min per kidney). Filtration fraction was increased in untreated diabetic rats because of the increase in glomerular filtration rate but not in l-arginine– or l-citrulline–treated diabetic rats. Urinary protein excretion was increased in untreated and l-arginine–treated diabetic rats (142±25 versus 75±7 and 128±7 versus 89±7 μg/min per kidney) but not in diabetic rats administered l-citrulline (67±7 versus 61±5 μg/min per kidney). The diabetes mellitus–induced tissue hypoxia, because of elevated oxygen consumption, was unaltered by any of the treatments. l-citrulline administered to diabetic rats increases plasma l-arginine concentration, which prevents the diabetes mellitus–induced glomerular hyperfiltration, filtration fraction, and proteinuria, possibly by a vascular effect.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24866144     DOI: 10.1161/HYPERTENSIONAHA.114.03519

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Combined systems pharmacology and fecal metabonomics to study the biomarkers and therapeutic mechanism of type 2 diabetic nephropathy treated with Astragalus and Leech.

Authors:  Ruiqun Chen; Chengbin Liao; Qian Guo; Lirong Wu; Lei Zhang; Xiufeng Wang
Journal:  RSC Adv       Date:  2018-08-01       Impact factor: 4.036

2.  Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.

Authors:  Mark F McCarty
Journal:  Healthcare (Basel)       Date:  2017-03-14

3.  L-Citrulline Supplementation-Increased Skeletal Muscle PGC-1α Expression is Associated With Exercise Performance and Increased Skeletal Muscle Weight.

Authors:  Myra O Villareal; Toshiya Matsukawa; Hiroko Isoda
Journal:  Mol Nutr Food Res       Date:  2018-05-24       Impact factor: 5.914

4.  Impaired pressure natriuresis and non-dipping blood pressure in rats with early type 1 diabetes mellitus.

Authors:  Geoffrey J Culshaw; Hannah M Costello; David Binnie; Kevin R Stewart; Alicja Czopek; Neeraj Dhaun; Patrick W F Hadoke; David J Webb; Matthew A Bailey
Journal:  J Physiol       Date:  2018-12-23       Impact factor: 5.182

5.  Endothelial arginine resynthesis contributes to the maintenance of vasomotor function in male diabetic mice.

Authors:  Ramesh Chennupati; Merlijn J P M T Meens; Vincent Marion; Ben J Janssen; Wouter H Lamers; Jo G R De Mey; S Eleonore Köhler
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

6.  Kidney Mass Reduction Leads to l-Arginine Metabolism-Dependent Blood Pressure Increase in Mice.

Authors:  Samyuktha Muralidharan Pillai; Petra Seebeck; Ralph Fingerhut; Ji Huang; Xiu-Fen Ming; Zhihong Yang; François Verrey
Journal:  J Am Heart Assoc       Date:  2018-02-25       Impact factor: 5.501

7.  Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice.

Authors:  Saki Ichikawa; Tomohito Gohda; Maki Murakoshi; Zi Li; Eri Adachi; Takeo Koshida; Yusuke Suzuki
Journal:  FEBS Open Bio       Date:  2020-05-18       Impact factor: 2.693

8.  Inducible Slc7a7 Knockout Mouse Model Recapitulates Lysinuric Protein Intolerance Disease.

Authors:  Susanna Bodoy; Fernando Sotillo; Meritxell Espino-Guarch; Maria Pia Sperandeo; Aida Ormazabal; Antonio Zorzano; Gianfranco Sebastio; Rafael Artuch; Manuel Palacín
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.